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ABSTRACT
p63 is a crucial regulator of epidermal development,
but its transcriptional control has remained elusive.
Here, we report the identification of a long-range
enhancer (p63LRE) that is composed of two evolu-
tionary conserved modules (C38 and C40), acting
in concert to control tissue- and layer-specific ex-
pression of the p63 gene. Both modules are in an
open and active chromatin state in human and mouse
keratinocytes and in embryonic epidermis, and are
strongly bound by p63. p63LRE activity is dependent
on p63 expression in embryonic skin, and also in
the commitment of human induced pluripotent stem
cells toward an epithelial cell fate. A search for other
transcription factors involved in p63LRE regulation
revealed that the CAAT enhancer binding proteins
Cebpa and Cebpb and the POU domain-containing
protein Pou3f1 repress p63 expression during ker-
atinocyte differentiation by binding the p63LRE en-
hancer. Collectively, our data indicate that p63LRE is
composed of additive and partly redundant enhancer
modules that act to direct robust p63 expression se-
lectively in the basal layer of the epidermis.
INTRODUCTION
The transcription factor (TF) p63, a p53 family member, is
a master regulator of epidermal morphogenesis as demon-
strated by the absence of surface epithelium in neonatal
mice lacking p63 (1,2). p63, and more specifically the more
abundant Np63 isoform, has been associated with sev-
eral crucial functions in epidermal cells including cell pro-
liferation and stem cell renewal (2–8), commitment to an
epidermal cell fate and to cell differentiation (1,7,9–14) and
cell adhesion (15–18).
During mouse embryonic development, p63 mRNA is
one of the earliest epidermal-specific markers to be detected
in the surface epithelium at embryonic day 8.5 (E8.5) (1–
2,10,19). At E10.5, ectodermal cells begin to express ker-
atin K5 and K14 mRNA in a highly region-specific pattern
similar to that of p63 (20). Suprabasal keratins K1 and K10
are expressed just before stratification occurs at E14.5 (20),
a process that is completed at E17.5 when the epidermis
acquires its barrier function. During stratification, p63 ex-
pression becomes progressively confined to the basal undif-
ferentiated layer of the epidermis, and is weakly expressed
or absent in the suprabasal differentiated layers (21,22). A
similar regulation of p63 expression is observed in human
and mouse keratinocytes in culture, in which p63 is highly
expressed under proliferative conditions and is downregu-
lated in differentiated cells (12,22–24).
The mouse p63 gene (Trp63) comprises a large genomic
portion (about 208 kb) on chromosome 16 (band 16qB1),
and contains 16 exons and two independent promoters (P1
and P2) that drive the expression of two classes of tran-
scripts: TAp63 containing an N-terminal transactivation
domain and Np63 lacking the TA domain and acting as
either transcriptional activator or repressor (25–28). Alter-
native splicing at the 3′ gives rise to three different carboxyl-
terminal isoforms designated ,  and  . TheNp63 pro-
tein containing the longest C-terminal domain is the most
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abundant isoform inmature proliferating stratified epithelia
such as those of the skin (21,22).
In spite of the essential role of p63 in development of
the epidermis and other stratified epithelia, little is known
about the regulation of p63 expression during epidermal de-
velopment and in keratinocyte differentiation. Studies in ze-
brafish and xenopus indicate that, during epidermal devel-
opment, p63 expression is induced by bone morphogenetic
protein (BMP) (29,30), consistent with the ability of BMP
signaling to act as an epidermal inducer and a suppressor
of neural cell fate during development (31,32). Similarly,
in human and mouse embryonic stem cells, and induced
pluripotent stem cells (iPSCs), active BMP signaling is re-
quired for epidermal or corneal epithelial lineage commit-
ment and for p63 expression (33–35). In contrast to BMP
signaling, Notch is active prior to the onset of p63 expres-
sion in ectodermal progenitor cells and negatively regulates
p63 expression in both developing mouse embryos and in
human embryonic stem cells (35). At later developmental
stages, Notch signaling is a crucial positive regulator of ker-
atinocyte terminal differentiation (36–39), and negatively
regulates p63 mRNA levels at least in part by inhibiting
interferon responsive factors IRF3 and IRF7 (12). In ad-
dition, IRF6, another IRF family member with a specific
role in epidermal development and differentiation (40,41),
has been shown to downregulate p63 protein levels in a
proteasome-dependent manner (42).
In spite of these observations, the mechanisms regulating
p63 expression are still not fully understood. We previously
reported that neither the TAp63 (2 kb) nor the Np63 (4
kb) promoters are sufficient to confer keratinocyte-specific
expression to a luciferase reporter gene (43), although a
number of TFs including Sp1/Sp3 and NF-Y bind and reg-
ulate the Np63 promoter (44). Similarly, a 10-Kb human
genomic fragment upstream of the Np63 transcription
start site (TSS) is insufficient to mimic endogenous Np63
expression in mammary epithelial cells (45). Thus, other
regulatory elements are likely required to regulate tissue-
specific expression of the p63 transcripts.
Developmental control genes, such as p63, often com-
prise a large genomic portion with numerous cis-regulatory
elements, and tend to have longer introns consistent with
the fact that introns frequently harbor enhancer regions (re-
viewed in (46)). We previously identified an evolutionary
conserved regulatory element (C40) located in p63 intron
5, the largest intron downstream of Np63 promoter (P2),
that drivesweak expression in the epidermis during embryo-
genesis (43). p63 binds C40 thereby sustaining its own ex-
pression in cooperation with AP-2, a family of crucial regu-
lators of epidermal genes in embryonic development (47–
49). However, the C40 element drives expression in both
basal and suprabasal compartments in vivo, and is unaf-
fected by calcium-induced differentiation in cultured ker-
atinocytes, suggesting that other regulatory elements are re-
quired for basal cell-specific expression.
Here, we report the identification of a novel evolutionar-
ily conserved cis-regulatory element (C38) that acts syner-
gistically with the previously characterized C40 enhancer to
activate keratinocyte-specific transcription. A 12-kb mouse
genomic region encompassing the two regulatory elements
is sufficient to drive robust basal specific expression in em-
bryonic and newborn skin. Layer-specific regulation is likely
caused by direct binding of Cebpa and Cebpb and Pou3f1,
known regulators of epidermal differentiation, to both C38
and C40. Accordingly, depletion of these transcriptional
regulators relieves differentiation-dependent p63 downreg-
ulation.
MATERIALS AND METHODS
Cell cultures, plasmids, transfection and reporter assays
Mouse primary keratinocytes were isolated from C57BL/6
newborn mice and cultured under low calcium conditions
(0.05 mM) in the presence of 4% calcium-chelated Fetal
Bovine Serum (FBS) (Invitrogen, Carlsbad, CA, USA) and
Epidermal Growth Factor (EGF, Invitrogen) as previously
described (43). Terminal differentiation was induced by ad-
dition of calcium chloride to the medium (0.6 mM or 2
mM for 12, or 24 h as specified). Human primary ker-
atinocytes were kindly provided by Dr. G.P. Dotto, and cul-
tured in Keratinocyte-Serum Free Medium supplemented
with bovine pituitary extracts (30 g/ml) and EGF (0.2
ng/ml) (Invitrogen). Mouse dermal fibroblasts were cul-
tured inDulbecco’smodified Eagle’s medium supplemented
with 10% FBS. Mouse C38 and C40 genomic regions were
cloned in the TK-pGL3 luciferase reporter plasmid (43)
(see Supplementary Data). p63LRE-TK-luc, C38, C40
and C38C40 were obtained by recombineering (see
Supplementary Data). Cells were transfected using Lipo-
fectamine 2000 (Invitrogen) with plasmids pCMV-Klf4
and pCMV-Klf5 (provided by Dr. Tommaso Russo; (50)),
pCMV-FoxN1 and pCMV-NIC (activated Notch1) (pro-
vided by Dr. GP Dotto; (36)), pBabe-Cebpa (provided by
Dr. Go¨khan S. Hotamisligil; (51)), pBabe-Cebpb (provided
by Dr. Roberto Mantovani), pXCX-Pou2f3 and pXCX-
Pou3f1 (provided by Dr. Bogi Andersen; (52)). Luciferase
activity was determined 48 h after transfection with the
dual-luciferase reporter assay kit (Promega). Renilla activ-
ity was used to normalize transfection efficiency. p63, Irf6,
Cebpa, Cebpb, Pou2f3, Pou3f1 knockdown were obtained
by transient transfection of 100 nM small interfering RNA
(siRNA) (see Supplementary Data for specific sequences).
Human iPSCs were obtained by lentiviral infection of pri-
mary dermal fibroblasts derived from a healthy individ-
ual or an individual carrying the R304W mutation in the
p63 DNA binding domain causative of EEC syndrome (ec-
trodactyly, ectodermal dysplasia and cleft lip/palate syn-
drome). Human iPSCs were differentiated in vitro in the
presence of corneal fibroblasts conditioned medium and
BMP-4 as previously described (53). C38C40-luc was trans-
fected using Fugene HD (Promega) and luciferase was de-
tected at days 4 and 8 by Luciferase assay kit (Promega).
Generation of transgenic mice and ß-galactosidase staining
A 12-kb genomic region spanning C38 and C40 enhancers
(p63LRE) was cloned in the modified -globin–lacZ vector
p1229 (43) by recombineering (see Supplementary Data).
The p63LRE-LacZ construct was linearized, purified and
injected into fertilized oocytes of DBA X C57BL/6 mice
at the CBRC Transgenic Facility (Massachusetts General
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Hospital, Boston, MA) and at the Transgenic Facility (De-
partment of Molecular Biotechnology and Health Sci-
ences, University of Turin). Nineteen pups were gener-
ated, six of which were positive by polymerase chain re-
action (PCR) and three also expressed the LacZ trans-
gene in a similar tissue-specific pattern. -Galactosidase
staining was previously described (43). Founders were
backcrossed with C57BL/6 mice to establish mouse lines.
p63−/−; p63LRE-LacZ mice were obtained crossing p63+/−
mice with p63LRE-LacZ transgenic mice. All mouse exper-
iments were approved by the Italian Ministry of Health.
Bioinformatics analysis of TF binding site and mutagenesis
Analysis of TF binding sites was performed using MatIn-
spector Matrix Family Library Version 9.0 (August 2012)
(GenomatixSuite v3.0) (54). Alignment of conserved non-
coding element C38 in different species was performed with
the ClustalW program (http://www.ebi.ac.uk/clustalw/).
Mutagenesis reactions were performed using QuikChange
Lightning Site-DirectedMutagenesis Kit (Agilent) with the
indicated oligonucleotides (see Supplementary Data).
Real-time RT-PCR, ChIP and immunoblotting analyses
RNA was extracted in TRIzol reagent (Invitrogen) and
treated with DNase I (Roche). Complementary DNA
(cDNA) synthesis was obtained using SuperScript Vilo (In-
vitrogen). Expression of target genes was normalized for the
-actin gene expression. ChIP analysis was performed as
previously described (43) using rabbit polyclonal antibody
anti-p63 (H137, Santa Cruz Biotechnology), anti-histone
H3K4me3 (Upstate 07–473), anti-H3K27Ac (Diagenode),
anti-Cebpa (14AA, SantaCruzBiotechnology), anti-Cebpb
(C-19, Santa Cruz Biotechnology), anti- Pou3f1 (kindly
provided by Dr. Michael Wegner, Universita¨t Erlangen-
Nu¨rnberg, Germany) (55) or rabbit anti-mouse IgG (Santa
Cruz Biotechnology). Real-time RT-PCR was performed
using the SYBR Green PCR master mix (Applied Biosys-
tems) in an ABI PRISM 7500 (Applied Biosystems).
Oligonucleotide sequences are given in the Supplementary
Data. For immunoblotting, cells were lysed in sample buffer
and immunoblotted as previously described (43). The fol-
lowing primary antibodies were used: anti-p63 (4A4, Santa
Cruz Biotechnology), anti--actin (Santa Cruz Biotech-
nology). For immunoblotting, secondary antibodies were
sheep anti-mouse IgG conjugated to horseradish perox-
idase (GE Healthcare) and visualized using Enhanced
chemiluminescence (ECL) western blotting system (GE
Healthcare).
Statistics
All quantitative results are presented as mean ± SD of in-
dependently repeated experiments as indicated in the figure
legends. Statistical significance was assessed by Student’s t
test using Microsoft Excel. P-value (P) is indicated in each
single experiment.
RESULTS
Identification of a novel enhancer region in the p63 gene
To identify regulatory elements that may contribute to
tissue-specific expression of p63, we previously performed a
comparative sequence analysis of the p63 genomic region in
vertebrates and characterized the highly conserved intronic
C40 enhancer (43). In this analysis, another mouse genomic
element (C38), located 7.6 kb upstream of the C40 and 33
kb downstream of the Np63 TSS, was identified with a
similarly high degree of conservation in even the most dis-
tant vertebrates (43,56) (Figure 1A). Given the high degree
of evolutionary conservation restricted to the exons and the
C38 and C40 element only, we hypothesized that C38 could
be an important regulatory element for p63 expression in
spite of the low enhancer activity when tested in transacti-
vation assays (43).
Histone modifications have proven effective in determin-
ing the location of cis-regulatory elements (reviewed in
(57)). To test whether C38 was a putative enhancer, ChIP-
qPCR was performed in mouse keratinocytes and embry-
onic skin using antibodies specific for acetylated H3K27
(H3K27ac), known to identify active regulatory regions in-
cluding promoters and enhancers (58). As expected a strong
signal was detected in keratinocyte for theNp63 promoter
(P2), consistent with high expression of Np63 in these
cells, whereas no signal was observed in the TAp63 pro-
moter (P1), in a control region located 20kb upstream P1 or
in p63 intron 1 (Figure 1B). Interestingly, a strong signal was
detected in C38 and C40 both in mouse keratinocytes and
in embryonic skin at E14.5 (Figure 1B and Supplementary
Figure S1A), demonstrating that these elements are active
regulatory regions. Conversely, H3K4me3, that marks pro-
moter regions (59), bound specifically to the active Np63
promoter (P2), but did not bind to either C38 or C40 (Fig-
ure 1C). In addition, using ENCODE data (60) a strong
H3K27ac signal was detected on the C38 and C40 elements
in human keratinocytes and in human mammary epithelial
cells, but not in other cell types that do not express p63, con-
sistent with the presence of active and specific enhancers in
those genomic regions (Supplementary Figure S2). DNAse
hypersensitive sites were detected in both C38 and C40 ele-
ments in human cells (Supplementary Figure S2), indicating
that they are in an open chromatin state.
In addition ChIP-on-chip experiments in mouse ker-
atinocytes revealed that in a genomic region spanning the
Np63 transcript plus 20 kb upstream of TSS, the p63 pro-
tein bound strongly and uniquely to the C38 and C40 el-
ements (25) (Figure 1A). Supporting and extending these
data, two independent genome-wide ChIP-seq analyses per-
formed in human primary keratinocytes (61,62) revealed
that in a 1-Mb region comprising the p63 locus, p63 protein
bound to the C38 and C40 genomic elements with the high-
est signal scores (Supplementary Figure S2). ChIP-qPCR
analysis confirmed that p63 efficiently bound both C38 and
C40 inmouse primary keratinocytes, in postnatal epidermis
and in embryonic skin (Figure 1D and E; Supplementary
Figure S1B). Similar results were obtained in human ker-
atinocytes (Figure 1F), suggesting that the function of these
genomic elements is conserved between human and mice.
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Figure 1. (A) Upper panel: mouse p63 gene structure. The P1 (TA) and P2 (N) promoters are indicated. C38 and C40 correspond to highly conserved
sequences in evolution as determined by the 17-way alignment predicted by the phastCons program (56). Genomic elements identified by ChIP-on-chip
experiment using p63 antibodies are indicated with black squares (25). Lower panel: evolutionary conservation of the C38 element in multiple vertebrate
species. Conserved nucleotides are shown in gray, and identical nucleotides in all species are indicated by stars (Clustal consensus). (B,C) ChIP-qPCR
was performed on mouse primary keratinocyte using antibodies anti-H3K27Ac (B), anti-H3K4me3 (C) (gray bars) or rabbit IgG (black bars) as negative
control. (D,E,F) ChIP-qPCR was performed on primary mouse keratinocytes (D), mouse newborn epidemis (E) and human keratinocytes (F) using p63
polyclonal antibodies (H-137) (gray bars), or rabbit IgG (black bars) as negative control. Oligonucleotide sequences are listed in Supplementary Data.
Error bars denote SD.
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C38 and C40 elements cooperate to sustain transcription in
basal keratinocytes
Since both C38 and C40 are highly conserved in evolution,
display an active chromatin state and are bound by p63,
we tested the hypothesis that these elements may act syn-
ergistically to regulate p63 expression. For this purpose, we
generated a reporter construct containing both genomic el-
ements upstreamof the thymidine kinaseminimal promoter
driving the luciferase reporter gene (C38C40-Luc), and we
tested its enhancer activity. The C38C40 transactivation ac-
tivity was stronger than the C40 enhancer alone in mouse
keratinocytes consistent with a synergistic contribution of
the two elements (Figure 2A), whereas C38 had a very low
enhancer activity by itself as previously reported (43).
In primary keratinocytes under basal conditions, p63
was expressed at high levels whereas its expression was
reduced both at the RNA and protein levels in calcium-
induced differentiation (Figure 2B and C) as previously re-
ported (23,24). Regulatory elements conferring specificity
to p63 expression in undifferentiating versus differentiat-
ing conditions have not been identified. C40 activity was
poorly affected under differentiating conditions, whereas
the C38C40 enhancer activity was strongly inhibited in
mouse keratinocytes induced to differentiate by calcium
treatment compared to the basal condition (Figure 2A).
To test the possibility that the two elements may have
a similar synergistic response in undifferentiated condi-
tions and may be responsive to calcium-induced differen-
tiation even at their physiological distance, a 12 kb mouse
genomic region comprising both elements was cloned in
a luciferase reporter vector (p63LRE-Luc). Transactiva-
tion assays revealed a strong and specific enhancer activ-
ity in keratinocytes but not in fibroblasts (Figure 2D), in-
dicating that p63LRE acts in a cell type-specific manner.
In undifferentiating keratinocytes, deletion of the C40 el-
ement (p63LREC40) or concomitant deletion of both
C38 and C40 elements (p63LREC38C40) abolished
p63LRE enhancer activity, whereas the absence of C38 el-
ement (p63LREC38) had little or no effect (Figure 2D).
Similar to C38C40, p63LRE enhancer activity was inhib-
ited in mouse keratinocytes induced to differentiate by cal-
cium treatment compared to undifferentiating conditions,
whereas p63LREC38maintained a strong enhancer activ-
ity under both basal and differentiating conditions, demon-
strating that the C38 element is required to confer respon-
siveness to differentiation (Figure 2E). The contribution of
C40 in differentiating conditions could not be evaluated
since p63LREC40 lost transactivation activity under both
basal and differentiating conditions (Figure 2E).
LRE enhancer activity recapitulates p63 expression in a
mouse model
To test the significance of these findings in vivo, we gen-
erated transgenic mice carrying the p63LRE upstream of
the -galactosidase gene (p63LRE-LacZ). The p63LRE en-
hancer activity drove strong and specific expression in the
developing and newborn epidermis. At E10.5 LacZ expres-
sion was observed in the branchial arches and in the api-
cal ectodermal ridge, with a similar but much stronger pat-
tern of expression compared to the previously character-
ized C40×4-LacZ transgenic mice (Figure 3A). In addition,
at this stage p63LRE drove expression in cells of the fa-
cial processes, the dorsal epidermal sheet and the tail bud,
that never scored positive in the C40×4-LacZ. At E13.5
ß-galactosidase staining was present at the tip of the de-
veloping limbs, in the mammary buds, in the snout epi-
dermis and to a lesser extent in several other areas of the
skin (Supplementary Figure S3A). At E15.5 LacZ expres-
sion was detected in the entire embryonic skin of p63LRE-
LacZ mice, whereas under the same experimental condi-
tions, it was much weaker in the C40×4-LacZ mice (Fig-
ure 3B). In p63LRE-LacZ newborn mice, a strong and
basal-specific LacZ expression was observed in the epider-
mis and in the hair follicles, whereas aweaker and diffuse ex-
pressionwas detected in C40×4-LacZ skin (Figure 3C). Co-
localization of the ß-galactosidase staining and p63 expres-
sion was confirmed by immunohistochemistry with anti-
p63 antibodies in p63LRE-LacZ skin (Supplementary Fig-
ure S3B), demonstrating that the p63LRE enhancer drives
LacZ expression with a pattern identical to the endogenous
p63.
p63 is required for LRE enhancer activity
Since p63 protein binds both the C38 and C40 elements,
we tested the possibility that p63 may be essential for
p63LRE activity. In cultured p63-deficient keratinocytes,
both C38C40 and p63LRE activities were markedly inhib-
ited compared to p63 expressing cells (Supplementary Fig-
ure S4). To test whether the p63LRE enhancer was depen-
dent on p63 expression also in vivo, we obtained mice carry-
ing p63LRE enhancer driving LacZ expression in a p63−/−
background (p63−/−; p63LRE-LacZ). Accordingly, LacZ
expression was not detected in p63−/−; p63LRE-LacZ epi-
dermis at E15.5 (Figure 4A and B), indicating that p63 is
essential for p63LRE enhancer activity both in vitro and in
vivo.
To assess the requirement of p63 for the enhancer activity
in epithelial commitment in vitro, we measured the C38C40
activity during epithelial differentiation of human iPSCs
(Figure 4D). p63 is required for induction of an epidermal
or corneal epithelial lineage commitment, two fates that are
defective in cells derived from EEC patients (53). Using this
system, we found that the enhancer activity was progres-
sively activated in iPSC differentiation in parallel with p63
expression (Figure 4C and D). Importantly, p63 enhancer
activity was impaired in iPSCs derived from an individual
affected by EEC syndrome and carrying a deleterious mis-
sense mutation in p63, indicating that the p63 enhancer is
dependent on p63 expression and is a useful tool to follow
its activity.
A subset of TFs involved in keratinocyte differentiation regu-
lates p63LRE activity
To identify the TFs regulating p63LRE activity, C38 and
C40 sequences were analyzed for putative TF binding sites.
Consistent with data shown above, bioinformatics analy-
sis revealed putative evolutionary conserved p63 consensus
sequences not only in C40 as previously reported (43) but
also in C38 (Supplementary Figure S5 and Supplementary
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Figure 2. (A) C38-Luc, C40-Luc and C38C40-Luc enhancer activity was analyzed in primary mouse keratinocytes under proliferation (low calcium; white
bars) and differentiation conditions (high calcium; gray bars) upon 24 h of calcium treatment (Ca++ 2 mM). Data are expressed relative to TK promoter
activity used as control (*P ≤ 0.05; ***P ≤ 0.0005; n = 4). (B,C) p63 expression was detected at the mRNA (B) and protein (C) levels in primary mouse
keratinocytes in proliferating and in calcium-induced differentiated keratinocytes at the indicated times (Ca++ 2 mM). (D) p63LRE luciferase activity
was tested in mouse dermal fibroblasts (Fib) and primary keratinocytes (Ker). (E) TK-Luc construct carrying p63LRE, p63LREC38, p63LREC40
and p63LREC38C40 were tested for luciferase activity in primary mouse keratinocytes under proliferation (white bars) and differentiation (gray bars)
conditions (***P ≤ 0.0005; n = 6). Error bars denote SD.
Table S1). Concomitant mutations of canonical p53/p63
binding site conserved in human and chicken identified by
bioinformatics analysis in the C38 and C40 elements al-
most completely abolished C38C40 enhancer activity (Fig-
ure 5A). Since p63 expression is reduced during differen-
tiation, we tested the hypothesis that the suppression of
C38C40 enhancer activity in differentiating keratinocytes
may be a consequence of reduced p63 protein levels. Sur-
prisingly, C38C40 carrying deletions in the p63 binding
sites was equally responsive to calcium induced differen-
tiation even if its overall activity was reduced, indicating
that reduced enhancer activity in differentiated cells was not
merely a consequence of a progressive reduction in the p63
protein level (Figure 5B).
In addition to p63, we identified a number of pu-
tative sequence motifs for TFs known to be involved
in keratinocyte differentiation including interferon regu-
latory factors (IRFs), Forkhead box family (FOXs or
FKHDs), Kru¨ppel-like family factors (KLFs), POU home-
obox factors (POUs) and CCAAT/enhancer binding pro-
teins (C/EBPs) (Supplementary Figure S5 and Supplemen-
tary Table S1). Despite its crucial role in epidermal differ-
entiation (63), overexpression of the Kru¨ppel-like factor 4
(Klf4) or of its family member Klf5 had no significant ef-
fect on the C38C40 activity (Figure 5C). Similarly, no ef-
fect was observed upon overexpression of the Forkhead box
protein n1 (Foxn1), a regulator of epidermal and of hair
follicle differentiation (64–67), or of a constitutively active
Notch1 (Figure 5C), suggesting that Notch1 is likely to sup-
press p63 expression in a C38C40 independent manner.
In contrast, a significant repression of C38C40 enhancer
activity was observed when Irf6, Cebpa, Cebpb, Pou2f3
(Skn-1a) and Pou3f1 (Tst-1) were overexpressed in mouse
keratinocytes (Figure 5C). Expression levels of Cebpa,
Cebpb, Irf6, Pou2f3 and Pou3f1 were all induced in dif-
ferentiating keratinocytes as compared to undifferentiat-
ing conditions (Supplementary Figure S6A and SB), con-
sistent with their functions in differentiated keratinocytes,
and their crucial role in skin development and epidermal
differentiation (40,68–71). To further explore the role of
these TFs on C38 and C40 elements, we tested the ef-
fect of their depletion on C38C40 enhancer activity in ker-
atinocytes using specific siRNA. Depletion of each TF
induced C38C40 enhancer activity in differentiated ker-
atinocytes (Figure 5D), indicating that these TFs have a sig-
nificant inhibitor activity on the enhancer.
Direct regulation of LRE enhancer activity by a subset of TFs
involved in keratinocyte differentiation
To determine whether any of the TFs that inhibit p63LRE
function may be acting through physical interaction with
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Figure 3. (A) E10.5 wild type (WT) and transgenic embryos containing four copies of C40 (C40×4-LacZ) or p63LRE-LacZ were tested for -galactosidase
activity. (B) Embryos at E15.5 were tested for -galactosidase activity as in (A). (C) Histological sections of skin at P2 were processed for -galactosidase
staining and counterstained with eosin. Scale bar, 50 m.
the enhancer elements, ChIP were performed using specific
antibodies. ChIP experiments in mouse and human ker-
atinocytes indicated that Irf6 was unable to bind directly to
either C38 or C40 (Supplementary Figure S7A and data not
shown), consistent with previous ChIP-seq data (Antonio
Costanzo, personal communication and (72)). In contrast,
ChIP experiments performed in mouse keratinocytes us-
ing Cebpa- or Cebpb-specific antibodies revealed that these
TFs bound both C38 and C40 elements to a similar ex-
tent (Figure 6A and B). Binding of Pou2f3 could not be as-
sessed due to the lack of ChIP grade antibodies, however
ChIP experiments using Pou3f1 antibodies indicated that
Pou3f1 efficiently bound to both C38 and C40 (Figure 6C).
In addition, ChIP experiments performed in differentiated
keratinocytes revealed an increased Cebpa binding to the
C38 element compared to proliferating conditions, whereas
p63 binding was reduced upon calcium treatment (Supple-
mentary Figure S7B). To further explore the putative role
of each TF in regulating p63 expression, we analyzed p63
mRNA and protein levels in proliferating and differenti-
ated keratinocytes using TF-specific siRNA. Interestingly,
p63 expression levels were partially restored in differentiat-
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Figure 4. (A) E15.5 embryos carrying p63LRE in a wild type (+/+; p63LRE-LacZ) and in a p63-null background (-/-; p63LRE-LacZ) were tested for
-galactosidase activity. Wild-type (+/+) and p63-null (-/-) littermates were used as controls. (B) Histological sections of skin at E15.5 were obtained after
-galactosidase staining and were subsequently paraffin embedded and counterstained with eosin. Scale bar, 50 m. (C) p63 expression was detected at
the mRNA levels in human iPSCs at 0, 4 and 8 days (D0–D8) of corneal epithelial differentiation. Data are represented relative to p63 expression levels at
day 0 (*P ≤ 0.05; **P ≤ 0.005; n = 3). (D) Luciferase activity of C38C40-Luc was tested in human iPSCs (WT and EEC) at D0–D8 of corneal epithelial
differentiation. Data are represented relative to luciferase activity of TK control in D0 human iPSCs (*P ≤ 0.05; **P ≤ 0.005; n = 3).
ing conditions by depletion of Cebpa, Cebpb, Pou2f3 and
Pou3f1 or by concomitant depletion of Cepba/Cebpb or
Pou2f3/Pou3f1 (Figure 6D and E; Supplementary Figure
S8A). Consistent with depletion studies, overexpression of
Cebpa and Cebpb suppressed p63 expression levels (Sup-
plementary Figure S8B). Taken together, these data indi-
cate that these TFs contribute to p63 suppression during
keratinocyte differentiation.
DISCUSSION
Here, we demonstrate that p63 transcription is regulated by
an evolutionary conserved molecular mechanism involving
a long-range enhancer, p63LRE. Two small genomic ele-
ments (C38 and C40) are essential for the p63LRE func-
tion and for basal keratinocyte-specific expression. These el-
ements are unique in the p63 genomic region for the follow-
ing reasons: (i) they represent the only two non-transcribed
elements to be evolutionarily conserved in the most distant
vertebrates; (ii) the p63 protein binds far more strongly to
these two elements than to any other region in the p63 ge-
nomic locus. Evolutionary sequence conservation has been
extensively used as filter to identify putative gene regulatory
elements (73). However, coupling sequence conservation
with ChIP studies using DNAseI sensitivity, histone acetyl-
transferase or H3K27ac as marks of active enhancers, more
precisely detects enhancer regions (58,74–78). We used the
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Figure 5. (A) Luciferase activity of the C38C40-Luc carrying either WT or mutant p63-binding sites (p63BSmut) was tested in mouse keratinocytes. Data
are expressed as the% of wild type luciferase activity (***P ≤ 0.0005; n = 3). (B) The activity of wild type C38C40, C38C40p63BSmut and TK control
was tested in proliferating (low Ca++; white bars) and differentiated keratinocytes (2 mM Ca++; gray bars), and plotted as% of each luciferase activity
in low Ca++ conditions. (***P ≤ 0.0005; n = 3). (C) C38C40-Luc luciferase activity in the absence (−) or in the presence of expression vectors carrying
the indicated TFs in mouse keratinocytes. (***P ≤ 0.0005; n = 7). (D) C38C40 luciferase activity was tested in differentiated (gray bars) and proliferating
(white bars) mouse keratinocytes upon transfection of the indicated siRNAs. (*P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.0005; n = 3). Error bars denote SD.
H3K27ac mark and p63 binding, coupled to transgenic
mouse assays to examine p63LRE function. Comparative
genomic analysis has revealed that enhancers active during
early embryogenesis are evolutionarilymore conserved than
those active after mid-gestation (75). C38 and C40 are char-
acterized by strong binding of p63 andH3K27ac not only in
mouse keratinocytes and in newborn epidermis but also in
embryonic epidermis, consistent with the early activation of
p63LRE in embryogenesis. In agreement with an evolution-
arily conserved function of the enhancer in p63-expressing
epithelial cells, H3K27ac is detected in human keratinocytes
and in mammary epithelial cells, but not in other six hu-
man cell types that are known to be devoid of p63. Thus,
our data suggest that p63LRE belongs to the enhancer cat-
egory that is not stage- or species-specific, but rather plays a
fundamental role in regulating tissue-specific expression of
the endogenous p63 gene.
In some cases, enhancers can bypass a nearby gene in
order to activate a more distal transcription unit. For in-
stance, the enhancer regulating Sonic Hedgehog in the de-
veloping limbs is located 1 Mb away, within the intron of
another gene (79). We have strong reasons to believe that
p63LRE regulates p63 expression: (i) p63 is the only gene
in a 2-Mb genomic region with a precocious and spatially
restricted expression in embryonic skin that fully overlaps
with p63LRE enhancer activity ((23) and our unpublished
observations); (ii) distal transcriptional enhancers are of-
ten associated with genes controlling critical developmental
processes (73,80–81) such as p63, the only gene in the locus
to have such a crucial regulatory function in development.
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Figure 6. (A, B, C) ChIP-qPCRwas performed onmouse primary keratinocytes using antibodies specific for Cebpa (A), Cebpb (B), Pou3f1 (C) (gray bars)
or rabbit IgG as negative control (white bars). (D) p63 mRNA expression levels in differentiated (gray bars) and proliferating (white bars) keratinocytes
upon transfection of the indicated siRNAs. (*P≤ 0.05; **P≤ 0.005; ***P≤ 0.0005; n= 4). Error bars denote SD. (E) Immunoblotting of total cell extracts
from primary mouse keratinocytes transfected as in (D) using antibodies against the indicated proteins. Keratinocytes were cultured in proliferation (low
Ca++) or in differentiation conditions (0.6 mM Ca++ for 24 h).
Direct and indirect positive autoregulation by a DNA-
binding TF is a widely used strategy to ensure the long-
term maintenance of its own gene expression, after the ini-
tiating signals and factors are no longer present (82,83).
p63 protein positively controls its own transcription in a di-
rect manner by strongly binding to both C38 and C40 ele-
ments. p63-depletion causes loss of p63LRE enhancer ac-
tivity both in vitro and in vivo suggesting that this autoreg-
ulation is central to the control of the p63 gene expression
after other initiating signals, possibly including BMP (29–
30,33,35). Whether BMP signaling controls p63 expression
in the developing surface ectoderm in mammals remains
unclear. We found that SMAD1 is unable to bind p63LRE
or Np63 promoter in BMP-stimulated keratinocytes (our
unpublished observations), however the possibility that
BMP/SMAD signaling may control p63LRE in early de-
velopment cannot be excluded. Nevertheless, careful dis-
section of the enhancer activity at different stages of de-
velopment revealed that p63LRE becomes active after p63
expression, indicating that the enhancer is unlikely to con-
tain binding sites for upstream transcriptional activators re-
quired to turn on p63. This hypothesis is consistent with
the notion that developmentally regulated genes, such as
p63, often have a complex transcriptional regulation with
many enhancer modules contributing in a cumulative man-
ner to the overall spatial and temporal regulation of the gene
(84,85).
In addition, interconnected functional gene networks,
rather than individual TFs, control single enhancers. Ac-
cordingly, besides p63 we found that Cebpa, Cebpb and
Pou3f1 bind both C38 and C40 directly. C/EBPs are mem-
bers of a highly conserved family of leucine zipper TFs in-
volved in the control of cellular proliferation and differen-
tiation of a number of cell types (86). Concomitant epider-
mal ablation of Cebpa and Cebpb leads to increased basal
keratinocyte proliferation and severe defects in keratinocyte
commitment and differentiation coupled with suprabasal
expression of p63 (71). Although it has been shown that the
DNA-binding domain of Cebpa is required for suppression
of p63 expression, no direct regulation could be demon-
strated (71). Here, we show that the suppression of p63 ex-
pression is due to a direct binding of Cebpa and Cebpb to
the p63LRE elements. Other C/EBP family members may
be involved in p63 regulation, such as Cebpd that has been
reported to negatively regulate p63 in epidermis by binding
the Np63 promoter (87).
The two POU homeobox proteins, Pou2f3 and Pou3f1,
are both expressed in the epidermis andmore abundantly in
the suprabasal compartment (69). Depletion of both POU
proteins in mice has no overt phenotype at birth while adult
skin is hyperplastic and fails to suppress expression of basal
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layer markers such as keratin14 (69). Our results show that
p63 is suppressed by both Pou2f3 and Pou3f1, and that
Pou3f1 binds directly to both C38 and C40 elements sug-
gesting a direct regulation. These data are consistent with
previous reports showing that Pou2f3 can repress K14 ex-
pression and that p63 and Pou2f3 exert antagonistic ef-
fects on K14 and other keratin expression (52,88). Thus, in-
creased expression of the Cebps and Pous and concomitant
reduced p63 expression are likely to be additively respon-
sible for the enhancer specificity and for p63 regulation in
cycling cells versus differentiating cells.
Consistent with the modularity of the enhancers, the re-
quirement of C38 and C40 in the p63LRE enhancer activ-
ity in both proliferation and differentiation conditions sug-
gests that C38 and C40 may have a partially overlapping
role in p63LRE enhancer to control p63 expression in the
epidermis. This is in agreement with the findings that sev-
eral TFs are capable of binding both C38 and C40. Divid-
ing the enhancer in various functionally connected and par-
tially redundant activities may confer flexibility and robust-
ness, preventing mutations from destroying the enhancer
function. C38 and C40 are also likely to have distinct func-
tions as C40 depletion leads to a significant decrease in the
p63LRE enhancer activity in all tested conditions, whereas
C38 depletion does not, however, combined with C40, C38
confers higher responsiveness to differentiation, confining
p63 expression in the basal keratinocytes of the epidermis.
Mutations in non-coding portions of the p63 gene have
not been described so far in any of the p63-related syn-
dromes. Future studies should be directed at exploring the
possibility that mutations or even relatively frequent se-
quence variations in the p63LREmay affect the penetrance
and the expressivity of p63-related syndromes.
Beside its relevance in p63 biology, the identification of
p63LRE will provide a useful tool to drive exogenous ex-
pression during embryonic development and in mature epi-
dermis mimicking p63 expression pattern. In addition, we
demonstrate here that p63LRE activity follows p63 expres-
sion in the conversion of iPSCs toward the epithelial cell
fate. Thus, p63LRE could be a potentially useful tool to im-
prove the efficiency of current protocols for iPSC differenti-
ation into corneal andmost likely epidermal differentiation,
or to identify candidate molecules that can revert defects in
p63 function in patient-derived iPSCs.
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